Source: BioSpace

TargEDys: TargEDys and SymbioPharm enter an exclusive partnership to launch SymbioLife Satylia in Germany

TargEDys and SymbioPharm signed an exclusive marketing and distribution agreement for the launch of SymbioLife® Satylia® in Germany.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Gregory Lambert's photo - CEO of TargEDys

CEO

Gregory Lambert

CEO Approval Rating

84/100

Read more